Is a complete JAGX research report available?

No complete published report is available for Jaguar Health, Inc. (JAGX) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Jaguar Health, Inc. (JAGX)

NASDAQ: JAGX · USD

$0.96

-0.07 (-6.5%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-25 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first JAGX analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	581K
Revenue (ttm)	29.6M
Net income (ttm)	-50.1M
EPS (ttm)	-$262
Shares out	603.1K
Volume	195,199
Beta	-0.09

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 29.6M
Net income (ttm): -50.1M
EPS (ttm): -$262
Market cap: 581K

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All JAGX indicators

Market & fundamental data

Available fields

199

Groups with data

Currency

USD

Showing 199 of 199 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001585608
Company name	Jaguar Health, Inc.
Country	United States
Country code	US
Cusip	47010C862
Employees	47
Employees Change	-2%
Employees Change Percent	-4.08
Enterprise value	$27.6M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
Isin	US47010C8626
Last refreshed	2026-07-25
Market cap	$580,999
Market cap category	Nano-Cap
Price	$0.96
Price currency	USD
Rev Per Employee	629,127.66x
Sector	Healthcare
Sector PE	44.8
Sector PE Fwd	23.59
Sic	2834
Symbol	JAGX
Website	https://jaguar.health

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-8,394.87%
EV Sales Forward	1.9x
EV/Sales	0.93x
FCF yield	-1,269.97%
P/S ratio	0.02x
PS Forward	0.04x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-88.96%
EBITDA Margin	-82.51%
Gross margin	85.06%
Gross Profit	$25.2M
Gross Profit Growth	164.42%
Gross Profit Growth Q	1,025.01%
Gross Profit Growth3 Y	38.86%
Gross Profit Growth5 Y	30.79%
Net Income	$-50.1M
Net Income Growth Quarters	1%
Net Income Growth Years	0%
Pretax Margin	-117.28%
Profit Margin	-115.39%
Profit Per Employee	$-1.1M
ROA	-35.86
Roa5y	-47.03
ROCE	-423
ROIC	-45.75

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-98.85%
Cagr3y	-96.8%
Cagr5y	-96.48%
EPS Growth Quarters	1
EPS Growth Years	11
Revenue Growth	155.96x
Revenue Growth Q	815.63x
Revenue Growth Quarters	1x
Revenue Growth Years	0x
Revenue Growth3 Y	37.79x
Revenue Growth5 Y	24.83x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.67
Assets	$37.4M
Cash	$7.3M
Current Assets	$20.2M
Current Liabilities	$31.2M
Debt	$34.3M
Equity	$-6.3M
Interest Coverage	-32
Liabilities	$43.7M
Long Term Assets	$17.2M
Long Term Liabilities	$12.5M
Net Cash	$-27M
Net Cash By Market Cap	$-4,527
Tangible Book Value	$-29.7M
Tangible Book Value Per Share	$-79.93
WACC	1.92

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.65
Inventory Turnover	0.48
Net Working Capital	$4.1M
Quick ratio	0.24
Working Capital	$-11M
Working Capital Turnover	$-6.74

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-1,474.87%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-98.84%
200-day SMA	25.91
3Y total return	-100%
50-day SMA	2.65
50-day SMA vs 200-day SMA	50under200
5Y total return	-100%
All Time High	6,280,000,000
All Time High Change	-100%
All Time High Date	2017-08-04
All Time Low	0.95
All Time Low Change	1.4%
All Time Low Date	2026-07-24
ATR	0.28
Beta	-0.09
Beta1y	2.09
Beta2y	2.52
Ch YTD	-97.04
High	1.08
High52	92.75
High52 Date	2025-08-12
High52ch	-98.96%
Low	0.95
Low52	0.95
Low52 Date	2026-07-24
Low52ch	1.4%
Ma50ch	-63.7%
Premarket Change Percent	0.97
Premarket Price	$1.04
Premarket Volume	1,084
Price vs 200-day SMA	-96.28%
RSI	19.15
RSI Monthly	17.05
RSI Weekly	29.02
Sharpe ratio	-2.03x
Sortino ratio	-2.77
Total Return	-1,474.87%
Tr YTD	-97.04
Tr1m	-62.37%
Tr1w	-25.9%
Tr3m	-93.02%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	$-25.5M
Operating margin	-86.26

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	576,576%
Float Percent	95.6%
Net Borrowing	3,048,000
Shares Insiders	4.4%
Shares Institutions	3.44%
Shares Out	603,134
Shares Qo Q	240.66%
Shares Yo Y	1,474.87%
Short Float	12.8%
Short Ratio	0.83
Short Shares	12.24

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-8.3M
Average Volume	77,842.5x
Bv Per Share	-38.11
CAPEX	$-41,000
Ch1m	-62.37
Ch1w	-25.9
Ch1y	-98.84
Ch3m	-93.02
Ch3y	-100
Ch5y	-100
Ch6m	-96.4
Change	-6.48%
Change From Open	-7.37
Close	1.03
Days Gap	0.97
Depreciation Amortization	1,907,000
Dollar Volume	188,035.2
Earnings Date	2026-08-13
Earnings Time	bmo
EBIT	$-26.3M
EBITDA	$-24.4M
EPS	$-262
F Score	4
FCF	$-7.6M
FCF EV Yield	-27.44x
FCF Per Share	$-12.57
Financing CF	12,089,000
Fiscal Year End	December
Founded	2,013
Investing CF	-41,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-20
Last Report Date	2026-03-31
Last Split Date	2026-04-30
Last Split Type	Reverse
Last10k Filing Date	2026-04-07
Ma150	14.99
Ma150ch	-93.57%
Ma20	2.11
Ma20ch	-54.39%
Net CF	4,374,000
Next Earnings Date	2026-08-13
Open	1.04
Optionable	No
Position In Range	10.23
Post Close	0.96
Postmarket Change Percent	10.56
Postmarket Price	$1.07
Ppne	1,502,000
Pre Close	1.03
Price Date	2026-07-24
Relative Volume	2.51x
Revenue	29,569,000x
SBC By Revenue	2.32x
Share Based Comp	685,000
Tr6m	-96.4%
Us State	California
Views	199
Volume	195,199
Z Score	-16.37

Jaguar Health, Inc. (JAGX)

Coverage state: Market snapshot only — no published research

Generate the first JAGX analysis

Price

Financial snapshot

Fair-value bridge

Latest news · JAGX

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All JAGX indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on JAGX

Frequently asked questions